Incretins Role in the Pathophysiology of Type 2 Diabetes Mellitus

被引:0
|
作者
Mythili, S., V [1 ]
机构
[1] Sree Balaji Med Coll & Hosp, Dept Biochem, Madras 600044, Tamil Nadu, India
来源
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2015年 / 6卷 / 06期
关键词
Incretins; Insulin resistance; Type II Diabetes Mellitus; pathophysiology;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Type 2 Diabetes Mellitus (T2DM) is characterized by the decreased responsiveness of tissues to insulin known as Insulin resistance. There may also be Insulin secretary defects in advanced stages. The insulin secretion is initiated by incretins, the two intestinal hormones namely, Glucose dependant Insulinotropic Polypeptide (GIP) & Glucagon like Polypeptide1(GLP-1). They are secreted when food enters the stomach. These hormones are shown to be reduced in T2DM. Hence, the probable role of Incretins in the pathophysiology of T2DM is reviewed here. Many number of studies have been undertaken on the physiology of Incretins and their role in causation of type2 diabetes mellitus. The literature analysis and compilation of results is given here. The level of incretins are much reduced in type 2 diabetes mellitus leading on to reduction in the secretion of insulin and elevation in the level of glucagon. Incretins are necessary to prevent the occurrence of Type 2 Diabetes Mellitus.
引用
收藏
页码:698 / 702
页数:5
相关论文
共 50 条
  • [1] Targeting Incretins in Type 2 Diabetes Mellitus
    Potenza, Matthew
    Rayfield, Elliot J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2009, 76 (03): : 244 - 256
  • [2] Pathophysiology of Type 2 Diabetes Mellitus
    Galicia-Garcia, Unai
    Benito-Vicente, Asier
    Jebari, Shifa
    Larrea-Sebal, Asier
    Siddiqi, Haziq
    Uribe, Kepa B.
    Ostolaza, Helena
    Martin, Cesar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 34
  • [3] The physiology and pharmacology of incretins in type 2 diabetes mellitus
    Holst, Jens J.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 14 - 21
  • [4] INNOVATIONS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: USE OF INCRETINS
    Dedov, I. I.
    Shestakova, M. V.
    Sukhareva, O. Yu
    TERAPEVTICHESKII ARKHIV, 2010, 82 (10) : 5 - 10
  • [5] Pathophysiology and complications of type 2 diabetes mellitus
    Reinehr, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (10) : 927 - +
  • [6] Tipping the Balance: the Pathophysiology of Obesity and Type 2 Diabetes Mellitus
    McKenney, Rachel L.
    Short, Daniel K.
    SURGICAL CLINICS OF NORTH AMERICA, 2011, 91 (06) : 1139 - +
  • [7] Emerging Concepts in The Pathophysiology of Type 2 Diabetes Mellitus
    Surampudi, Prasanth N.
    John-Kalarickal, Jennifer
    Fonseca, Vivian A.
    MOUNT SINAI JOURNAL OF MEDICINE, 2009, 76 (03): : 216 - 226
  • [8] Novel approach to pathophysiology of type 2 diabetes mellitus
    Mukhamedzhanov, E. K.
    Esyrev, O. V.
    DIABETES MELLITUS, 2013, 16 (04): : 49 - 51
  • [9] Incretins beyond type 2 diabetes
    Mathieu, Chantal
    Ahmadzai, Iraj
    DIABETOLOGIA, 2023, 66 (10) : 1809 - 1819
  • [10] Gene expression in the pathophysiology of type 2 diabetes mellitus
    Patti M.-E.
    Current Diabetes Reports, 2004, 4 (3) : 176 - 181